Patients in England could have faster access to effective cancer treatments through the reincarnated Cancer Drugs Fund (CDF), the National Institute for Health and Care Excellence (NICE) has announced.
Alderley Edge, United Kingdom – As a result of expanding business and a desire to better serve its European client base, Pennside Partners today announced the opening of a new office in Alderley Edge, UK, 25 KM south of Manchester.
Nearly one million people are diagnosed with cancer in the United States per year, according to The American Cancer Society, and although cancer therapeutics are among the most active areas in drug development, treatment still falls short of meeting patients’ needs.
The British pharmaceutical industry is facing new challenges following the UK’s decision to leave the European Union, a white paper has revealed. Published by Global Data, it warned of wide-reaching impacts.
3D printing has been making waves since 1984 when its inventor, Charles Hull, used the technology to make a 3D model from a picture, demonstrating that this technology would be a revolutionary way to test a product design before sinking big money into a large manufacturing program.
Pennside Partners, Ltd. is a leading business development consulting firm serving the pharmaceutical, biotechnology, and medical device sectors worldwide.
In the past, data from clinical trials of new drugs and medical devices have been the property of the companies that designed them, and they were allowed to control how and what data was released.
